FDA Import Refusal BGK-9231146-4/20003/1 — Exzell Pharma
The FDA refused shipment BGK-9231146-4/20003/1 from Exzell Pharma (Canada) on Oct 29, 2025. The refused product falls under Drugs and Biologics — OXYMETAZOLINE HCL (ADRENERGIC). Cited charges: 118,3280,75
Refusal details
- Date
- Oct 29, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 60CAQ48 OXYMETAZOLINE HCL (ADRENERGIC)
- Charges
- 118,3280,75